179 related articles for article (PubMed ID: 2299601)
21. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes.
Cribb AE; Spielberg SP; Griffin GP
Drug Metab Dispos; 1995 Mar; 23(3):406-14. PubMed ID: 7628308
[TBL] [Abstract][Full Text] [Related]
22. Hydroxylation of the antimalarial drug 58C80 by CYP2C9 in human liver microsomes: comparison with mephenytoin and tolbutamide hydroxylations.
Weaver RJ; Dickins M; Burke MD
Biochem Pharmacol; 1995 Mar; 49(7):997-1004. PubMed ID: 7741772
[TBL] [Abstract][Full Text] [Related]
23. Participation of a rat liver cytochrome P-450 induced by pregnenolone 16 alpha-carbonitrile and other compounds in the 4-hydroxylation of mephenytoin.
Shimada T; Guengerich FP
Mol Pharmacol; 1985 Aug; 28(2):215-9. PubMed ID: 4022003
[TBL] [Abstract][Full Text] [Related]
24. mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates.
Graham MJ; Bell AR; Crewe HK; Moorcraft CL; Walker L; Whittaker EF; Lennard MS
Xenobiotica; 2003 Mar; 33(3):225-37. PubMed ID: 12637241
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of tolbutamide metabolism by antimalarial drugs.
Karbwang J; Back DJ; Bunnag D; Breckenridge AM
Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):235-41. PubMed ID: 3227403
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2.
Yasumori T; Murayama N; Yamazoe Y; Kato R
Clin Pharmacol Ther; 1990 Mar; 47(3):313-22. PubMed ID: 2311333
[TBL] [Abstract][Full Text] [Related]
27. Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.
Doecke CJ; Veronese ME; Pond SM; Miners JO; Birkett DJ; Sansom LN; McManus ME
Br J Clin Pharmacol; 1991 Feb; 31(2):125-30. PubMed ID: 2049228
[TBL] [Abstract][Full Text] [Related]
28. Hydroxylation and formation of electrophilic metabolites of tienilic acid and its isomer by human liver microsomes. Catalysis by a cytochrome P450 IIC different from that responsible for mephenytoin hydroxylation.
Dansette PM; Amar C; Valadon P; Pons C; Beaune PH; Mansuy D
Biochem Pharmacol; 1991 Feb; 41(4):553-60. PubMed ID: 1997003
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism in stereoselective hydroxylations of mephenytoin and hexobarbital by Japanese liver samples in relation to cytochrome P-450 human-2 (IIC9).
Kato R; Yamazoe Y; Yasumori T
Xenobiotica; 1992; 22(9-10):1083-92. PubMed ID: 1441599
[TBL] [Abstract][Full Text] [Related]
30. Gliclazide hydroxylation by rat liver microsomes.
Rieutord A; Stupans I; Shenfield GM; Gross AS
Xenobiotica; 1995 Dec; 25(12):1345-54. PubMed ID: 8719909
[TBL] [Abstract][Full Text] [Related]
31. Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes.
Hall SD; Guengerich FP; Branch RA; Wilkinson GR
J Pharmacol Exp Ther; 1987 Jan; 240(1):216-22. PubMed ID: 2879902
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P-450 human-2 (P-450IIC9) in mephenytoin hydroxylation polymorphism in human livers: differences in substrate and stereoselectivities among microheterogeneous P-450IIC species expressed in yeasts.
Yasumori T; Yamazoe Y; Kato R
J Biochem; 1991 May; 109(5):711-7. PubMed ID: 1917894
[TBL] [Abstract][Full Text] [Related]
33. Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s.
Aoyama T; Korzekwa K; Nagata K; Gillette J; Gelboin HV; Gonzalez FJ
Endocrinology; 1990 Jun; 126(6):3101-6. PubMed ID: 2161748
[TBL] [Abstract][Full Text] [Related]
34. Mephenytoin-type polymorphism of drug oxidation: purification and characterization of a human liver cytochrome P-450 isozyme catalyzing microsomal mephenytoin hydroxylation.
Gut J; Meier UT; Catin T; Meyer UA
Biochim Biophys Acta; 1986 Dec; 884(3):435-47. PubMed ID: 3096378
[TBL] [Abstract][Full Text] [Related]
35. Relationship between mephenytoin, phenytoin and tolbutamide hydroxylations in healthy African subjects.
Horsmans Y; Kanyinda JM; Desager JP
Pharmacol Toxicol; 1996 Feb; 78(2):86-8. PubMed ID: 8822040
[TBL] [Abstract][Full Text] [Related]
36. Anticancer drugs as inhibitors of two polymorphic cytochrome P450 enzymes, debrisoquin and mephenytoin hydroxylase, in human liver microsomes.
Relling MV; Evans WE; Fonné-Pfister R; Meyer UA
Cancer Res; 1989 Jan; 49(1):68-71. PubMed ID: 2908853
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetics and polymorphism of human P-450 which activates and detoxicates xenobiotics and carcinogens.
Kato R; Yamazoe Y; Yasumori T
Princess Takamatsu Symp; 1990; 21():45-53. PubMed ID: 2134689
[TBL] [Abstract][Full Text] [Related]
38. Hepatic microsomal tolbutamide hydroxylation in Japanese: in vitro evidence for rapid and slow metabolizers.
Chen LS; Yasumori T; Yamazoe Y; Kato R
Pharmacogenetics; 1993 Apr; 3(2):77-85. PubMed ID: 8518837
[TBL] [Abstract][Full Text] [Related]
39. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility.
Treluyer JM; Gueret G; Cheron G; Sonnier M; Cresteil T
Pharmacogenetics; 1997 Dec; 7(6):441-52. PubMed ID: 9429229
[TBL] [Abstract][Full Text] [Related]
40. Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography.
Meier UT; Kronbach T; Meyer UA
Anal Biochem; 1985 Dec; 151(2):286-91. PubMed ID: 4096368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
